Literature DB >> 17303842

Early termination of drug trials.

Gorm Boje Jensen, John Hampton.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17303842      PMCID： PMC1800989          DOI： 10.1136/bmj.39113.534919.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  What have we learnt from Vioxx?

Authors:  Harlan M Krumholz; Joseph S Ross; Amos H Presler; David S Egilman
Journal:  BMJ       Date:  2007-01-20

2.  Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

Authors:  Christian M Jespersen; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm B Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian Gluud
Journal:  BMJ       Date:  2005-12-08

3.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

Review 4.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

5.  Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.

Authors:  Michael H Davidson; James M McKenney; Charles L Shear; James H Revkin
Journal:  J Am Coll Cardiol       Date:  2006-11-07       Impact factor: 24.094

6.  Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.

Authors:  James M McKenney; Michael H Davidson; Charles L Shear; James H Revkin
Journal:  J Am Coll Cardiol       Date:  2006-11-07       Impact factor: 24.094

7.  Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

Authors:  Margaret E Brousseau; Ernst J Schaefer; Megan L Wolfe; LeAnne T Bloedon; Andres G Digenio; Ronald W Clark; James P Mancuso; Daniel J Rader
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245
  7 in total
  1 in total

1.  The conscientious judgement of a DSMB--statistical stopping rules re-examined.

Authors:  Karin Hedenmalm; Hans Melander; Gunnar Alvan
Journal:  Eur J Clin Pharmacol       Date:  2007-11-14       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.